Whether your goal is to lose weight, manage type 2 diabetes, or explore metabolic health improvements, telehealth services now make it easier than ever to get safe, doctor-supervised access to these medications all from home
Generally speaking, injectables/parenterals are the space that has had the strongest hold on the oral GLP-1 agonists market
This approval marked an important milestone as the first GLP-1 receptor agonist to reduce the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in these patient populations
Research-grade IGF-1 DES is available only to qualified, licensed medical professionals
These results suggest that GLP-1R signaling contributes directly to symptom generation, and its inhibition could represent a novel therapeutic pathway